LISINOPRIL
NDC 76282-731, LISINOPRIL, tablet, from Exelan Pharmaceuticals, Inc.
- Product NDC
- 76282-731
- Status
- Listed
- Labeler
- Exelan Pharmaceuticals, Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076102
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76282-731 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISINOPRIL20 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76282-731-01 | 76282073101 | 100 TABLET in 1 BOTTLE (76282-731-01) |
| 76282-731-05 | 76282073105 | 500 TABLET in 1 BOTTLE (76282-731-05) |
| 76282-731-10 | 76282073110 | 1000 TABLET in 1 BOTTLE (76282-731-10) |
| 76282-731-18 | 76282073118 | 180 TABLET in 1 BOTTLE (76282-731-18) |
| 76282-731-30 | 76282073130 | 30 TABLET in 1 BOTTLE (76282-731-30) |
| 76282-731-45 | 76282073145 | 45 TABLET in 1 BOTTLE (76282-731-45) |
| 76282-731-50 | 76282073150 | 5000 TABLET in 1 BOTTLE (76282-731-50) |
| 76282-731-90 | 76282073190 | 90 TABLET in 1 BOTTLE (76282-731-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4aad4d30-3e18-489c-80ad-ccf7532bb933NADAC price for package 76282073101
GET /v1/drugs/nadac/76282073101NADAC price for package 76282073110
GET /v1/drugs/nadac/76282073110NADAC price for package 76282073118
GET /v1/drugs/nadac/76282073118NADAC price for package 76282073145
GET /v1/drugs/nadac/76282073145NADAC price for package 76282073150
GET /v1/drugs/nadac/76282073150NADAC price for package 76282073190
GET /v1/drugs/nadac/76282073190
Use it
Look up 76282-731 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76282-731 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76282-731. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.